Therapeutic Updates from the ADA 2026 Standards of Care

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!



In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, review key therapy-focused updates from the 2026 ADA Standards of Care, emphasizing areas they view as practice-changing.



Key Episode Timestamps

00:00:01 Intro

00:00:29 Adding GLP-1 RAs to heart failure

00:02:45 GLP-1s in glycemic management

00:04:36 Time in range targets in glycemic management

00:08:10 ADA recommends GLP-1s for T1D

00:12:00 GLP-1s in MASH and MASLD

00:12:57 Changes in kidney protection guidelines

00:14:40 New therapeutic guidance for T1D and T2D

00:17:57 Outro